5.41

4.33% -0.2343

Bioharvest Sciences Inc (BHST)

Overview News Price History Discussions Forecast

Bioharvest Sciences Inc stock is traded at $5.41, with a volume of 6,292. It is down -4.33% in the last 24 hours and down -14.01% over the past month. BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Previous Close:

$5.6443

Open:

$4.99

24h Volume:

6,292

Relative Volume:

0.89

Market Cap:

$86.47M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+9.06%

1M Performance:

-14.01%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$4.99

$5.39

1-Week Range:

$4.7237

$5.6443

52-Week Range:

$4.7237

$6.85

Bioharvest Sciences Inc Stock (BHST) Company Profile

Name

Bioharvest Sciences Inc

Sector

Healthcare (1190)

Industry

Biotechnology (686)

Phone

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

BHST's Discussions on Twitter

Compare BHST with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BHST Bioharvest Sciences Inc	5.39	86.47M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	487.67	125.43B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	711.12	76.60B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	668.67	39.57B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	275.94	35.33B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	122.01	28.08B	3.30B	-501.07M	1.03B	-2.1146

Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-18-24	Initiated	Maxim Group	Buy

Bioharvest Sciences Inc Stock (BHST) Latest News

Jan 24, 2025

When Will BioHarvest Sciences Inc. (CSE:BHSC) Become Profitable? - Simply Wall St

Jan 24, 2025

Jan 23, 2025

BioHarvest Sciences appoints veteran technology leader to board of directors - Proactive Investors USA

Jan 22, 2025

BioHarvest Announces Appointment of Sharon Malka to Board of Directors - Newsfile

Jan 22, 2025

Bioharvest Sciences Inc. Appoints Sharon Malka as Independent Director -January 22, 2025 at 08:34 am EST - Marketscreener.com

Jan 22, 2025

OTC Markets Group Announces Quarterly Index Performance and Rebalancing - GlobeNewswire Inc.

Jan 22, 2025

BioHarvest Sciences Strengthens Board with Healthcare Industry Veteran Sharon Malka - StockTitan

Jan 22, 2025

Jan 20, 2025

BioHarvest Sciences positioned for ‘legacy year’ in 2025, building on momentum with new innovations and strategic collaborations - Proactive Investors USA

Jan 20, 2025

Jan 09, 2025

BioHarvest Sciences doubles VINIA business, eyes growth By Investing.com - Investing.com Australia

Jan 09, 2025

Jan 08, 2025

CSE Bulletin: NV Issuer DesignationBioHarvest Sciences Inc. (BHSC) - Newsfile

Jan 08, 2025

BioHarvest Sciences CEO reflects on transformative 2024, outlines vision for future growth - Proactive Investors UK

Jan 08, 2025

BioHarvest Sciences Unveils Strategic Growth Initiatives with New CDMO Division - TipRanks

Jan 08, 2025

BioHarvest Sciences doubles VINIA business, eyes growth - Investing.com

Jan 08, 2025

BioHarvest Issues Shareholder Letter and Provides Corporate Update - Yahoo Finance

Jan 08, 2025

Dec 21, 2024

BioHarvest Sciences (NASDAQ:BHST) Earns Buy Rating from Analysts at Maxim Group - Defense World

Dec 21, 2024

Dec 18, 2024

Maxim Group sets Buy rating on BioHarvest Sciences shares, cites robust growth - Investing.com India

Dec 18, 2024

BioHarvest Sciences (NASDAQ:BHST) Now Covered by Maxim Group - MarketBeat

Dec 18, 2024

Dec 14, 2024

BioHarvest Sciences CEO discusses Tate & Lyle partnershipICYMI - Proactive Investors USA

Dec 14, 2024

Dec 12, 2024

Clean the SkyBotanical Sweetener Partnerships - Trend Hunter

Dec 12, 2024

BioHarvest Sciences shares keep buy rating, partnership drives optimism By Investing.com - Investing.com South Africa

Dec 12, 2024

BioHarvest Sciences shares keep buy rating, partnership drives optimism - Investing.com India

Dec 12, 2024

Tate & Lyle and BioHarvest collaboration to pioneer next gen plant-based ingredients - Food and Drink Technology

Dec 12, 2024

Dec 11, 2024

BioHarvest Sciences Partners with Tate & Lyle to Develop Sustainable Plant-Based Sweeteners - Proactive Investors USA

Dec 11, 2024

BioHarvest Sciences partners with Tate & Lyle to advance plant-based sweeteners - Proactive Investors UK

Dec 11, 2024

EXCLUSIVE: BioHarvest Collaborate With Tate & Lyle To Develop Proprietary Plant-Based Molecules - AOL

Dec 11, 2024

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology - Newsfile

Dec 11, 2024

Tate & Lyle Partners with BioHarvest Sciences to Revolutionize Plant-Based Sweeteners Using Breakthrough Technology - StockTitan

Dec 11, 2024

Dec 09, 2024

BHST News Today | Why did BioHarvest Sciences stock go up today? - MarketBeat

Dec 09, 2024

Dec 08, 2024

HC Wainwright Initiates Coverage on BioHarvest Sciences (NASDAQ:BHST) - Defense World

Dec 08, 2024

Nov 30, 2024

CNVCF (BioHarvest Sciences) GF Value Rank : 2 (As of Nov. 30, 2024) - GuruFocus.com

Nov 30, 2024

Nov 28, 2024

BioHarvest Sciences expands VINIA product line with launch of SuperFood Infused Teas - Proactive Investors Australia

Nov 28, 2024

Nov 27, 2024

BioHarvest Sciences Inc (CNVCF) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada

Nov 27, 2024

Nov 26, 2024